284 related articles for article (PubMed ID: 30115693)
21. PD-1 blockade enhances radio-immunotherapy efficacy in murine tumor models.
Zhuang Y; Li S; Wang H; Pi J; Xing Y; Li G
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1909-1920. PubMed ID: 30074066
[TBL] [Abstract][Full Text] [Related]
22. Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer Models.
Xu C; Zhang Y; Rolfe PA; Hernández VM; Guzman W; Kradjian G; Marelli B; Qin G; Qi J; Wang H; Yu H; Tighe R; Lo KM; English JM; Radvanyi L; Lan Y
Clin Cancer Res; 2017 Oct; 23(19):5869-5880. PubMed ID: 28679778
[No Abstract] [Full Text] [Related]
23. Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70.
Shevtsov MA; Pozdnyakov AV; Mikhrina AL; Yakovleva LY; Nikolaev BP; Dobrodumov AV; Komarova EY; Meshalkina DA; Ischenko AM; Pitkin E; Guzhova IV; Margulis BA
Int J Cancer; 2014 Nov; 135(9):2118-28. PubMed ID: 24691976
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.
Moran AE; Polesso F; Weinberg AD
J Immunol; 2016 Sep; 197(6):2509-21. PubMed ID: 27503208
[TBL] [Abstract][Full Text] [Related]
25. Effective anti-neu-initiated antitumor responses require the complex role of CD4+ T cells.
Mortenson ED; Park S; Jiang Z; Wang S; Fu YX
Clin Cancer Res; 2013 Mar; 19(6):1476-86. PubMed ID: 23363817
[TBL] [Abstract][Full Text] [Related]
26. Chimeric PD-1:28 Receptor Upgrades Low-Avidity T cells and Restores Effector Function of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy.
Schlenker R; Olguín-Contreras LF; Leisegang M; Schnappinger J; Disovic A; Rühland S; Nelson PJ; Leonhardt H; Harz H; Wilde S; Schendel DJ; Uckert W; Willimsky G; Noessner E
Cancer Res; 2017 Jul; 77(13):3577-3590. PubMed ID: 28533272
[TBL] [Abstract][Full Text] [Related]
27. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
[TBL] [Abstract][Full Text] [Related]
28. Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation.
Boer K; de Wit LE; Peters FS; Hesselink DA; Hofland LJ; Betjes MG; Looman CW; Baan CC
Clin Epigenetics; 2016; 8():116. PubMed ID: 27891189
[TBL] [Abstract][Full Text] [Related]
29. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.
Fu J; Kanne DB; Leong M; Glickman LH; McWhirter SM; Lemmens E; Mechette K; Leong JJ; Lauer P; Liu W; Sivick KE; Zeng Q; Soares KC; Zheng L; Portnoy DA; Woodward JJ; Pardoll DM; Dubensky TW; Kim Y
Sci Transl Med; 2015 Apr; 7(283):283ra52. PubMed ID: 25877890
[TBL] [Abstract][Full Text] [Related]
30. An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer.
Gitto SB; Kim H; Rafail S; Omran DK; Medvedev S; Kinose Y; Rodriguez-Garcia A; Flowers AJ; Xu H; Schwartz LE; Powell DJ; Simpkins F
Gynecol Oncol; 2020 Jan; 156(1):222-232. PubMed ID: 31818495
[TBL] [Abstract][Full Text] [Related]
31. The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNFα/IL17 Dependent.
Phan-Lai V; Dang Y; Gad E; Childs J; Disis ML
Clin Cancer Res; 2016 May; 22(9):2207-16. PubMed ID: 26660518
[TBL] [Abstract][Full Text] [Related]
32. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
33. Non-platelet-derived CXCL4 differentially regulates cytotoxic and regulatory T cells through CXCR3 to suppress the immune response to colon cancer.
Deng S; Deng Q; Zhang Y; Ye H; Yu X; Zhang Y; Han GY; Luo P; Wu M; Yu Y; Han W
Cancer Lett; 2019 Feb; 443():1-12. PubMed ID: 30481563
[TBL] [Abstract][Full Text] [Related]
34. T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target.
Mayer KE; Mall S; Yusufi N; Gosmann D; Steiger K; Russelli L; Bianchi HO; Audehm S; Wagner R; Bräunlein E; Stelzl A; Bassermann F; Weichert W; Weber W; Schwaiger M; D'Alessandria C; Krackhardt AM
Theranostics; 2018; 8(21):6070-6087. PubMed ID: 30613283
[TBL] [Abstract][Full Text] [Related]
35. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.
Bhat P; Leggatt G; Waterhouse N; Frazer IH
Cell Death Dis; 2017 Jun; 8(6):e2836. PubMed ID: 28569770
[TBL] [Abstract][Full Text] [Related]
36. Interferon-γ Production by Peripheral Lymphocytes Predicts Survival of Tumor-Bearing Mice Receiving Dual PD-1/CTLA-4 Blockade.
McNamara MJ; Hilgart-Martiszus I; Barragan Echenique DM; Linch SN; Kasiewicz MJ; Redmond WL
Cancer Immunol Res; 2016 Aug; 4(8):650-7. PubMed ID: 27262113
[TBL] [Abstract][Full Text] [Related]
37. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
38. Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.
Rodriguez-Ruiz ME; Rodriguez I; Garasa S; Barbes B; Solorzano JL; Perez-Gracia JL; Labiano S; Sanmamed MF; Azpilikueta A; Bolaños E; Sanchez-Paulete AR; Aznar MA; Rouzaut A; Schalper KA; Jure-Kunkel M; Melero I
Cancer Res; 2016 Oct; 76(20):5994-6005. PubMed ID: 27550452
[TBL] [Abstract][Full Text] [Related]
39. CCL21 and IFNγ recruit and activate tumor specific T cells in 3D scaffold model of breast cancer.
Phan-Lai V; Kievit FM; Florczyk SJ; Wang K; Disis ML; Zhang M
Anticancer Agents Med Chem; 2014 Feb; 14(2):204-10. PubMed ID: 24237220
[TBL] [Abstract][Full Text] [Related]
40. Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy.
Lee SS; Bindokas VP; Lingen MW; Kron SJ
Lab Invest; 2019 Sep; 99(9):1400-1413. PubMed ID: 30401959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
